FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

22428211000001105: Marixino 20mg tablets (Krka UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2575071000001113 Marixino 20mg tablets (Krka UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2575081000001110 Marixino 20mg tablets (Krka UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Marixino 20mg tablets (Krka UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Is a Memantine 20mg tablets true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Has active ingredient Memantine true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Has specific active ingredient Memantine hydrochloride true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Is a Maruxa true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Marixino 20mg tablets (Krka UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Marixino 20mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Marixino 20mg tablets (Krka UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start